Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
5.85
+0.01 (0.17%)
Nov 4, 2024, 4:00 PM EST - Market closed
Relay Therapeutics Employees
Relay Therapeutics had 323 employees as of December 31, 2023. The number of employees decreased by 4 or -1.22% compared to the previous year.
Employees
323
Change (1Y)
-4
Growth (1Y)
-1.22%
Revenue / Employee
$109,003
Profits / Employee
-$999,467
Market Cap
950.40M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 323 | -4 | -1.22% |
Dec 31, 2022 | 327 | 82 | 33.47% |
Dec 31, 2021 | 245 | 86 | 54.09% |
Dec 31, 2020 | 159 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Phibro Animal Health | 1,940 |
Weave Communications | 844 |
Autolus Therapeutics | 471 |
Arcutis Biotherapeutics | 296 |
IGM Biosciences | 224 |
Liquidia | 145 |
CARGO Therapeutics | 116 |
Mesoblast | 73 |
RLAY News
- 5 days ago - Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 - GlobeNewsWire
- 7 weeks ago - Relay Therapeutics: 2nd-Line RLY-2608 Data Moves Program Towards Expansion - Seeking Alpha
- 7 weeks ago - Relay Therapeutics' RLY-2608 Shows Promise For Breast Cancer With PI3Kα Mutations - Seeking Alpha
- 7 weeks ago - GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 7 weeks ago - Relay Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market - Benzinga
- 2 months ago - This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
- 2 months ago - Relay Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire